As Reported Financials

Document Name As Of Date Currency Code (in thousands) 2020 Y 10-K 12/31/2020 USD 2019 Y 10-K 12/31/2019 USD 2018 Y 10-K 12/31/2018 USD 2017 Y 10-K 12/31/2017 USD
Document Name As Of Date Currency Code 2020 Y 10-K 12/31/2020 USD 2019 Y 10-K 12/31/2019 USD 2018 Y 10-K 12/31/2018 USD 2017 Y 10-K 12/31/2017 USD

Operating Activities
Net income (loss) (38,013) 92,728 45,563 71,876

Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization 117,143 123,314 131,722 127,744
Impairment charges 67,226 37,610 49,739 0
Amortization of deferred financing costs 3,583 3,004 3,058 3,263
Gain on sale of assets (2,324) (43,422) 0 (6,943)
Loss on early extinguishment of debt NA NA NA 35,626
Equity in earnings of unconsolidated joint ventures (1,126) (7,839) (924) (1,937)
Equity-based compensation expense 12,517 18,120 14,669 13,585
Amortization of debt (premiums) and discounts, net 482 448 416 462
Amortization (accretion) of market rent rate adjustments, net 2,721 1,432 2,577 2,829
Straight-line rent adjustments 3,372 (7,721) (5,844) (5,632)
Distributions of cumulative earnings from unconsolidated joint ventures 3,490 7,587 7,941 10,697
Other non-cash 0 3,638 0 0
Changes in other asset and liabilities
Other assets (5,366) (4,159) 2,079 365
Accounts payable and accrued expenses 1,042 (4,288) 7,322 1,224
Net cash provided by operating activities 164,747 220,452 258,318 253,159

Investing Activities
Additions to rental property (28,566) (47,884) (64,253) (166,231)
Additions to investments in unconsolidated joint ventures (10,601) (2,316) (1,916) (5,892)
Net proceeds on sale of assets 7,626 128,505 0 39,213
Distributions in excess of cumulative earnings from unconsolidated joint ventures 9,071 17,819 25,232 25,084
Additions to non-real estate assets (1,872) (1,155) (1,330) (8,909)
Additions to deferred lease costs (3,061) (5,142) (6,703) (6,584)
Other investing activities 8,632 9,462 8,947 5,774
Net cash provided by (used in) investing activities (18,771) 99,289 (40,023) (117,545)

Financing Activities
Cash dividends paid (66,563) (132,664) (131,244) (130,166)
Distributions to noncontrolling interests in Operating Partnership (3,499) (7,018) (6,955) (6,800)
Proceeds from revolving credit facility 641,630 282,870 491,900 719,521
Repayments of revolving credit facility (641,630) (427,970) (554,900) (572,421)
Proceeds from notes, mortgages and loans 0 0 25,000 299,460
Repayments of notes, mortgages and loans (3,566) (3,369) (11,783) (373,258)
Payment of make-whole premium related to early extinguishment of debt NA NA NA (34,143)
Repurchase of common shares, including transaction costs 0 (20,000) (19,998) (49,361)
Employee income taxes paid related to shares withheld upon vesting of equity awards (736) (2,524) (2,068) (2,436)
Additions to deferred financing costs (1,891) (115) (4,428) (2,850)
Proceeds from exercise of options NA NA NA 54
Proceeds from other financing activities 72 47 626 12,054
Payment for other financing activities (1,410) (1,390) (1,353) (1,333)
Net cash used in financing activities (77,593) (312,133) (215,203) (141,679)
Effect of foreign currency rate changes on cash and cash equivalents (223) (19) (110) (56)
Net increase in cash, cash equivalents and restricted cash 68,160 7,589 2,982 (6,121)
Cash and cash equivalents, beginning of period 16,672 9,083 6,101 12,222
Cash and cash equivalents, end of period 84,832 16,672 9,083 6,101
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.